PMN310
PMN310 is a monoclonal antibody targeting amyloid-β oligomers (AβO) . PMN310 prevents AβO-induced memory loss and reduces synaptic loss and inflammation in vivo. PMN310 is potentially useful in Alzheimer's disease research[1].
Product Specifications
UNSPSC
12352211
Target
Amyloid-β
Related Pathways
Neuronal Signaling
Field of Research
Neurological Disease
References & Citations
[1]Gibbs E, et al. A Rationally Designed Humanized Antibody Selective for Amyloid Beta Oligomers in Alzheimer's Disease. Sci Rep. 2019 Jul 8;9 (1) :9870.
Shipping Conditions
Room temperature
Scientific Category
Inhibitory Antibodies
Clinical Information
No Development Reported
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog